Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 144

IDEXX Laboratories, Inc.

IDXXNASDAQEQUITYCurrent

SEC Filing

Filed May 20, 2026Accepted May 20, 2026, 6:30 PM EDTCIK 874716Accession 0001958244-26-000299
Share

Company context

IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions - to advance medical care, improve efficiency, and build thriving practices. Our innovations also help measure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500 ™ Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit www.idexx.com.

Current securities

Recent company filings

  1. 144 filingSep 4, 2026
  2. 4 filingAug 24, 2026
  3. 10-Q filingAug 4, 2026
  4. Results of Operations and Financial ConditionAug 4, 2026
  5. 4 filingJun 2, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗